Low-FODMAP Diet Versus Standard Dietary Advice in Irritable Bowel Syndrome: A Randomized Controlled Trial
DOI:
https://doi.org/10.5281/zenodo.22335681Keywords:
Low-FODMAP diet, Irritable bowel syndrome, Dietary advice, Gut microbiota, Symptom severityAbstract
Background: A diet low in fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) is widely recommended for irritable
bowel syndrome (IBS), but its benefit relative to standard first-line dietary advice remains debated. Objective: To synthesise trial and review evidence comparing low-FODMAP diet with standard dietary advice for symptom control, reintroduction/adherence, microbiota effects, and IBS subtypes. Methods: Narrative review of published randomised trials, systematic reviews/meta-analyses, and mechanistic studies. Findings: Head-to-head trials and pooled meta-analyses show low-FODMAP diet and standard dietary advice produce broadly equivalent global symptom response (50% vs 46% responders in one trial; 52% vs 41% in another), though low-FODMAP more consistently improves abdominal pain. Reintroduction restores tolerated FODMAPs and supports adherence, while restriction transiently reduces luminal Bifidobacteria. Conclusions: Both approaches are effective first-line options; standard advice first, with low-FODMAP reserved for non-responders and followed by structured reintroduction, is the most evidence-consistent strategy.
References
Sperber, A.D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U.C., Gwee, K.A., Hungin, A.P.S., Kang, J-Y., Minhu, C., Schmulson, M., Bolotin, A., Friger, M., Freud, T., Whitehead, W. (2017) The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut, 66(6): 1075-1082.
Gibson, P.R., Shepherd, S.J. (2010) Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of Gastroenterology and Hepatology, 25(2): 252-258.
McKenzie, Y.A., Bowyer, R.K., Leach, H., Gulia, P., Horobin, J., O'Sullivan, N.A., Pettitt, C., Reeves, L.B., Seamark, L., Williams, M., Thompson, J., Lomer, M.C.E. (2016) British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics, 29(5): 549-575.
Halmos, E.P., Power, V.A., Shepherd, S.J., Gibson, P.R., Muir, J.G. (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology, 146(1): 67-75.
Francis, C.Y., Morris, J., Whorwell, P.J. (1997) The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology and Therapeutics, 11(2): 395-402.
Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Simrén, M. (2015) Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology, 149(6): 1399-1407.
Eswaran, S.L., Chey, W.D., Han-Markey, T., Ball, S., Jackson, K. (2016) A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. American Journal of Gastroenterology, 111(12): 1824-1832.
Rej, A., Sanders, D.S., Shaw, C.C., Buckle, R., Trott, N., Agrawal, A., Aziz, I. (2022) Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome: a randomized trial of traditional dietary advice, the low FODMAP diet, and the gluten-free diet. Clinical Gastroenterology and Hepatology, 20(12): 2876-2887.
Nybacka, S., Törnblom, H., Josefsson, A., Hreinsson, J.P., Böhn, L., Fändemark, Å., Weznaver, C., Störsrud, S., Simrén, M. (2024) A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial. Lancet Gastroenterology and Hepatology, 9(6): 507-520.
Marsh, A., Eslick, E.M., Eslick, G.D. (2016) Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. European Journal of Nutrition, 55(3): 897-906.
Altobelli, E., Del Negro, V., Angeletti, P., Latella, G. (2017) Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients, 9(9): 940.
van Lanen, A-S., de Bree, A., Greyling, A. (2021) Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. European Journal of Nutrition, 60(6): 3505-3522.
Dionne, J., Ford, A.C., Yuan, Y., Chey, W.D., Lacy, B.E., Saito, Y.A., Quigley, E.M.M., Moayyedi, P. (2018) A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. American Journal of Gastroenterology, 113(9): 1290-1300.
Biesiekierski, J.R., Peters, S.L., Newnham, E.D., Rosella, O., Muir, J.G., Gibson, P.R. (2013) No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology, 145(2): 320-328.
Cuffe, M.S., Staudacher, H.M., Aziz, I., Coss Adame, E., Krieger-Grubel, C., Madrid, A.M., Ohlsson, B., Black, C.J., Ford, A.C. (2025) Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterology and Hepatology, 10(6): 520-536.
Peters, S.L., Yao, C.K., Philpott, H., Yelland, G.W., Muir, J.G., Gibson, P.R. (2016) Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 44(5): 447-459.
Whelan, K., Martin, L.D., Staudacher, H.M., Lomer, M.C.E. (2018) The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. Journal of Human Nutrition and Dietetics, 31(2): 239-255.
Van den Houte, K., Colomier, E., Routhiaux, K., Marién, Z., Schol, J., Van den Bergh, J., Vanderstappen, J., Pauwels, N., Joos, S., Arts, J., Caenepeel, P., De Clerck, F., Matthys, C., Meulemans, A., Jones, M., Vanuytsel, T., Carbone, F., Tack, J. (2024) Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in irritable bowel syndrome. Gastroenterology, 167(2): 333-342.
O'Keeffe, M., Jansen, C., Martin, L., Williams, M., Seamark, L., Staudacher, H.M., Irving, P.M., Whelan, K., Lomer, M.C. (2018) Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterology and Motility, 30(1): e13154.
Harvie, R.M., Chisholm, A.W., Bisanz, J.E., Burton, J.P., Herbison, P., Schultz, K., Schultz, M. (2017) Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World Journal of Gastroenterology, 23(25): 4632-4642.
Pouladi, A., Arabpour, E., Bahrami, O., Sadeghi, A., Mozafari Komesh Tape, P., Abdehagh, M., Zali, M.R. (2025) Impacts of the long-term low-FODMAP diet in patients with irritable bowel syndrome: a systematic review and meta-analysis. Journal of Human Nutrition and Dietetics, 38(4): e70105.
Halmos, E.P., Christophersen, C.T., Bird, A.R., Shepherd, S.J., Gibson, P.R., Muir, J.G. (2015) Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut, 64(1): 93-100.
Staudacher, H.M., Lomer, M.C.E., Farquharson, F.M., Louis, P., Fava, F., Franciosi, E., Scholz, M., Tuohy, K.M., Lindsay, J.O., Irving, P.M., Whelan, K. (2017) A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology, 153(4): 936-947.
Staudacher, H.M., Rossi, M., Kaminski, T., Dimidi, E., Ralph, F.S.E., Wilson, B., Martin, L.D., Louis, P., Lomer, M.C.E., Irving, P.M., Whelan, K. (2022) Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterology and Motility, 34(4): e14241.
Hustoft, T.N., Hausken, T., Ystad, S.O., Valeur, J., Brokstad, K., Hatlebakk, J.G., Lied, G.A. (2017) Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterology and Motility, 29(4): e12969.
Bennet, S.M.P., Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Öhman, L., Simrén, M. (2018) Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut, 67(5): 872-881.
Gibson, P.R., Halmos, E.P., So, D., Yao, C.K., Varney, J.E., Muir, J.G. (2022) Diet as a therapeutic tool in chronic gastrointestinal disorders: lessons from the FODMAP journey. Journal of Gastroenterology and Hepatology, 37(4): 644-652.
